Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3. These updates pertain to the page's versioning metadata rather than its study content.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices about government funding and prior Revision: v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice regarding government funding and NIH operations status has been added, and the site version has been updated from v3.4.0 to v3.4.1. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary is now displayed and QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Older QC entries and 'No FEAR Act' data have been removed.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page, as shown in the screenshots. This appears to be a metadata/version update and does not alter the study details or results.SummaryDifference0.1%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.